The global high content screening market was valued at USD 1,105 million in 2021 to USD 2,046 million by 2028, progressing at a CAGR of 9.2% from 2022 to 2028, according to Gen Consulting Company.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global high content screening market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the high content screening industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the component, application, end user, and region. The global market for high content screening can be segmented by component: consumables (reagents and kits), instrument or platform, services, software and analytics. In 2021, the instrument or platform segment made up the largest share of revenue generated by the high content screening market. High content screening market is further segmented by application: compound profiling, drug discovery, molecular diagnosis, oncology, toxicity studies, others. The drug discovery segment was the largest contributor to the global high content screening market in 2021. Based on end user, the high content screening market is segmented into: academic institutions, laboratories and pathology centers, pharmaceutical and biotechnology companies. The pharmaceutical and biotechnology companies segment is estimated to account for the largest share of the global high content screening market. On the basis of region, the high content screening market also can be divided into: Asia Pacific, Europe, North America, Rest of the World (RoW).

By component:
– consumables (reagents and kits)
– instrument or platform
– services
– software and analytics

By application:
– compound profiling
– drug discovery
– molecular diagnosis
– oncology
– toxicity studies
– others

By end user:
– academic institutions
– laboratories and pathology centers
– pharmaceutical and biotechnology companies

By region:
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)

The instrument market is further segmented into cytometers, detectors and sensors, imaging devices, liquid handling instruments, plate readers, others. Among these, the imaging devices segment was accounted for the highest revenue generator in 2021.

The report explores the recent developments and profiles of key vendors in the Global High Content Screening Market, including Agilent Technologies Inc., Bio-Rad Laboratories, Inc., Danaher Corp., GE Healthcare, Merck KGaA, Olympus Corporation, PerkinElmer, Inc., Sartorius AG, Thermo Fisher Scientific Inc., Yokogawa Electric Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global high content screening market.
– To classify and forecast the global high content screening market based on component, application, end user, region.
– To identify drivers and challenges for the global high content screening market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global high content screening market.
– To identify and analyze the profile of leading players operating in the global high content screening market.

Why Choose This Report
– Gain a reliable outlook of the global high content screening market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.